WOCKPHARMA

Wockhardt Share Price

₹1,310.10 +13.4 (1.03%)

04 May, 2025 07:55

SIP TrendupStart SIP in WOCKPHARMA

Start SIP

Performance

  • Low
  • ₹1,281
  • High
  • ₹1,333
  • 52 Week Low
  • ₹490
  • 52 Week High
  • ₹1,680
  • Open Price₹1,292
  • Previous Close₹1,297
  • Volume286,723

Investment Returns

  • Over 1 Month -7.65%
  • Over 3 Month -16.7%
  • Over 6 Month + 4.79%
  • Over 1 Year + 135.99%
SIP Lightning

Smart Investing Starts Here Start SIP with Wockhardt for Steady Growth!

Invest Now

Wockhardt Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -111.5
  • PEG Ratio
  • -1.8
  • Market Cap Cr
  • 21,287
  • P/B Ratio
  • 6.3
  • Average True Range
  • 74.44
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.74
  • RSI
  • 44.18
  • MFI
  • 60.28

Wockhardt Financials

Wockhardt Technicals

EMA & SMA

Current Price
₹1,310.10
+ 13.4 (1.03%)
pointer
  • stock-down_img
  • Bearish Moving Average 13
  • stock-up_img
  • Bullish Moving Average 3
  • 20 Day
  • ₹1,368.26
  • 50 Day
  • ₹1,368.94
  • 100 Day
  • ₹1,335.41
  • 200 Day
  • ₹1,195.88

Resistance and Support

1308.07 Pivot Speed
  • R3 1,386.93
  • R2 1,359.97
  • R1 1,335.03
  • S1 1,283.13
  • S2 1,256.17
  • S3 1,231.23

What's your outlook on Wockhardt?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Wockhardt Ltd. is a global pharmaceutical and biotechnology company specializing in the development, manufacturing, and marketing of medicines, vaccines, and biosimilars. It focuses on key therapeutic areas including anti-infectives, cardiology, and diabetes care.

Wockhardt has an operating revenue of Rs. 2,969.00 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -15% needs improvement, ROE of -13% is poor and needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 22% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Wockhardt Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-07 Quarterly Results
2024-11-13 Quarterly Results
2024-08-09 Quarterly Results
2024-05-28 Audited Results
2024-03-26 Others Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price. issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-.

Wockhardt F&O

Wockhardt Shareholding Pattern

49.09%
7.56%
0.51%
6.82%
0%
26.7%
9.32%

About Wockhardt

  • NSE Symbol
  • WOCKPHARMA
  • BSE Symbol
  • 532300
  • Managing Director
  • Dr. Murtaza Khorakiwala
  • ISIN
  • INE049B01025

Similar Stocks to Wockhardt

Wockhardt FAQs

Wockhardt share price is ₹1,310 As on 04 May, 2025 | 07:41

The Market Cap of Wockhardt is ₹21287.2 Cr As on 04 May, 2025 | 07:41

The P/E ratio of Wockhardt is -111.5 As on 04 May, 2025 | 07:41

The PB ratio of Wockhardt is 6.3 As on 04 May, 2025 | 07:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23